> top > docs > PMC:7556165 > spans > 56176-56318 > annotations

PMC:7556165 / 56176-56318 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T347 0-142 Sentence denotes The RAAS system is the target of widely used anti-hypertensive drugs, such as ACE-inhibitors (ACEI) and Ang-II type 1 receptor blockers (ARB).

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
1574 50-62 Disease denotes hypertensive MESH:D006973

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T5709 78-81 Protein denotes ACE https://www.uniprot.org/uniprot/Q9GLN7|https://www.uniprot.org/uniprot/Q9GLN6|https://www.uniprot.org/uniprot/Q9EQM9|https://www.uniprot.org/uniprot/Q8CFN1|https://www.uniprot.org/uniprot/Q7TMC6|https://www.uniprot.org/uniprot/Q7M4L4|https://www.uniprot.org/uniprot/Q6GTS2|https://www.uniprot.org/uniprot/Q59GY8|https://www.uniprot.org/uniprot/Q53YX9|https://www.uniprot.org/uniprot/Q50JE5|https://www.uniprot.org/uniprot/Q10751|https://www.uniprot.org/uniprot/Q0GA41|https://www.uniprot.org/uniprot/P47820|https://www.uniprot.org/uniprot/P22968|https://www.uniprot.org/uniprot/P22967|https://www.uniprot.org/uniprot/P22966|https://www.uniprot.org/uniprot/P12822|https://www.uniprot.org/uniprot/P12821|https://www.uniprot.org/uniprot/P12820|https://www.uniprot.org/uniprot/P09470|https://www.uniprot.org/uniprot/O02852|https://www.uniprot.org/uniprot/E7EU16|https://www.uniprot.org/uniprot/B4DXI3|https://www.uniprot.org/uniprot/B0LPF0|https://www.uniprot.org/uniprot/Q9VJV3

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T317 137-140 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1574 50-62 Disease denotes hypertensive MESH:D006973

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T347 0-142 Sentence denotes The RAAS system is the target of widely used anti-hypertensive drugs, such as ACE-inhibitors (ACEI) and Ang-II type 1 receptor blockers (ARB).